RA
Radiopharm Theranostics Limited (RADX)
NASDAQ·Healthcare·Biotechnology
$1.04
+16.99%
Mkt Cap $6.36M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+476.9%
Consensus $6.00 vs current $1.04
NASDAQ·Healthcare·Biotechnology
$1.04
+16.99%
Mkt Cap $6.36M
No recent rating data.
Price Target (3 analysts)
$6.00
Range $6.00 – $6.00
+476.9%
Consensus $6.00 vs current $1.04